<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01342848</url>
  </required_header>
  <id_info>
    <org_study_id>2010-021835-15</org_study_id>
    <nct_id>NCT01342848</nct_id>
  </id_info>
  <brief_title>Effectiveness of Thrombus Aspiration in Plaque Reduction for Patients With Acute Coronary Syndromes</brief_title>
  <acronym>REMNANT</acronym>
  <official_title>REduction of Myocardial Necrosis Achieved With Nose-dive Manual Thrombus Aspiration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Raffaele De Caterina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>San Giovanni Addolorata Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>G. d'Annunzio University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although successful, percutaneous coronary interventions (PCI) with stent implantation may be
      hampered by periprocedural myocardial necrosis. In acute ST-elevation myocardial infarction
      (STEMI), the reduction of thrombus burden through manual thrombus aspiration (TA) of an
      occluded coronary artery has been documented to produce an improved myocardial perfusion rate
      and significant survival advantage. To date, beyond feasibility and safety studies no
      clinical benefit has been yet documented with the use of TA before stent deployment in the
      setting of acute coronary syndromes (ACS) outside acute STEMI. The investigators hypothesize
      that TA before stent deployment reduces the thrombus/plaque burden - as assessed by
      intravascular imaging systems - in the setting of acute coronary syndromes (ACS) outside
      acute STEMI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periprocedural myocardial infarction (MI) has an independent adverse prognostic relevance.
      Several trials have documented a reduction in the occurrence of periprocedural MI through
      various pharmacological strategies, with enhanced inhibition of platelet aggregation or high
      dose statins. However, real-world registries still document an incidence of periprocedural MI
      in 30-40% of patients. Currently available intravascular imaging techniques, Intravascular
      Ultrasound (IVUS) and more recently available Optical Coherence Tomography (OCT) allow a
      precise evaluation of the coronary plaque and can be extremely useful for monitoring plaque
      modifications obtained with thrombus aspiration (TA). Plaque burden will be assessed as
      plaque + media (P+M), commonly measured with IVUS by subtracting lumen (L) to external
      elastic membrane (EEM) cross sectional area (P+M= EEM-L).

      Expecting a mean plaque volume of 160±50 mm3 in a population of patients with ACS undergoing
      PCI, a sample size of at least 45 patients (52 lesions) with a recent (&lt;15 days, but after 24
      hours) STEMI or a non-ST elevation (NSTE)-ACS within 72 hours of symptoms would provide a 90%
      power to detect a 20% reduction in the plaque volume after TA with an alpha (probability
      value) of 0.05.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>The change in plaque volume as assessed by intravascular ultrasound (IVUS).</measure>
    <time_frame>From baseline to 10 minutes after thromboaspiration (TA)</time_frame>
    <description>The reduction of plaque volume after TA, assessed as (Baseline P+M)- (Post-TA P+M);</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histopathology assessment of aspirated material.</measure>
    <time_frame>One week after PCI</time_frame>
    <description>Quantitative analysis: size and weight. Qualitative evaluation: a) thrombus containing only platelets, b) a thrombus with an erythrocyte component c) any fragment of vessel wall, cholesterol crystals, inflammatory cells or collagen tissue.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarct size by markers of myocardial injury/necrosis</measure>
    <time_frame>Up to 72 hours after PCI</time_frame>
    <description>Myocardial infarct size will be determined as the area under the curve of serial CK-MB and cardiac Troponin I assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change in thrombus burden as assessed by Optical Coherence Tomography (OCT)</measure>
    <time_frame>From baseline to 10 minutes after thromboaspiration (TA)</time_frame>
    <description>Thrombus burden will be assessed with a semiquantitative scale (0-4) by OCT at baseline and after TA</description>
  </secondary_outcome>
  <enrollment type="Actual">76</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Histopathology assessment of aspirated material during manual TA. Quantitative analysis: size
      and weight. Qualitative evaluation: a) thrombus containing only platelets, b) a thrombus with
      an erythrocyte component c) any fragment of vessel wall, cholesterol crystals, inflammatory
      cells or collagen tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        45 patients with at least one &quot;culprit&quot; lesion, identified as a high-grade (&gt;90%) lesion in
        the territory of jeopardized myocardium, at coronary angiography performed for a recent
        (&lt;15 days, but after 24 hours) STEMI or a non-ST elevation (NSTE)-ACS within 72 hours of
        symptoms.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18-75 years old.

          -  Recent(&lt;15 days, &gt;24 hrs)STEMI or NSTE-ACS within 72 hrs of symptoms.

          -  Presence at least one &quot;culprit&quot; high-grade (&gt;90%)lesion.

        Exclusion Criteria:

          -  STEMI within 24 hours.

          -  Cardiogenic shock, decompensated heart failure, LVEF&lt;30%.

          -  Serum creatinine ≥ 2.5 mg/dl.

          -  Contraindication to aspirin, heparin, thienopyridines.

          -  Total occlusion of target vessel.

          -  Diseased vein graft or a restenosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Center of Predictive Molecular Medicine - University &quot;G. d'Annunzio&quot;</name>
      <address>
        <city>Chieti</city>
        <zip>66013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology, G. d'Annunzio University</name>
      <address>
        <city>Chieti</city>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Giovanni Hospital and Centro per la Lotta Contro l'Infarto, Fondazione Onlus</name>
      <address>
        <city>Rome</city>
        <zip>00184</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W; Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005 Apr;26(8):804-47. Epub 2005 Mar 15.</citation>
    <PMID>15769784</PMID>
  </reference>
  <reference>
    <citation>Iakovou I, Mintz GS, Dangas G, Abizaid A, Mehran R, Kobayashi Y, Lansky AJ, Aymong ED, Nikolsky E, Stone GW, Moses JW, Leon MB. Increased CK-MB release is a &quot;trade-off&quot; for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2003 Dec 3;42(11):1900-5.</citation>
    <PMID>14662249</PMID>
  </reference>
  <reference>
    <citation>Prati F, Pawlowski T, Gil R, Labellarte A, Gziut A, Caradonna E, Manzoli A, Pappalardo A, Burzotta F, Boccanelli A. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study. Circulation. 2003 May 13;107(18):2320-5. Epub 2003 Apr 21.</citation>
    <PMID>12707236</PMID>
  </reference>
  <reference>
    <citation>Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD, Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):318-24. doi: 10.1002/ccd.21345. Review.</citation>
    <PMID>18288753</PMID>
  </reference>
  <reference>
    <citation>Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007 Oct;28(20):2525-38.</citation>
    <PMID>17951287</PMID>
  </reference>
  <reference>
    <citation>Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, Graf I, Ibrahim M, Pache J, Seyfarth M, Schühlen H, Dirschinger J, Berger PB, Schömig A; Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA. 2006 Apr 5;295(13):1531-8. Epub 2006 Mar 13.</citation>
    <PMID>16533938</PMID>
  </reference>
  <reference>
    <citation>Patti G, Colonna G, Pasceri V, Pepe LL, Montinaro A, Di Sciascio G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2005 Apr 26;111(16):2099-106. Epub 2005 Mar 6.</citation>
    <PMID>15750189</PMID>
  </reference>
  <reference>
    <citation>Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G; ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2004 Aug 10;110(6):674-8. Epub 2004 Jul 26.</citation>
    <PMID>15277322</PMID>
  </reference>
  <reference>
    <citation>Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008 Feb 7;358(6):557-67. doi: 10.1056/NEJMoa0706416.</citation>
    <PMID>18256391</PMID>
  </reference>
  <reference>
    <citation>Vlaar PJ, Diercks GF, Svilaas T, Vogelzang M, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F. The feasibility and safety of routine thrombus aspiration in patients with non-ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):937-42. doi: 10.1002/ccd.21717.</citation>
    <PMID>19021272</PMID>
  </reference>
  <reference>
    <citation>Zimarino M, Prati F, Stabile E, Pizzicannella J, Fouad T, Filippini A, Rabozzi R, Trubiani O, Pizzicannella G, De Caterina R. Optical coherence tomography accurately identifies intermediate atherosclerotic lesions--an in vivo evaluation in the rabbit carotid artery. Atherosclerosis. 2007 Jul;193(1):94-101. Epub 2006 Sep 27.</citation>
    <PMID>17007862</PMID>
  </reference>
  <reference>
    <citation>Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, Akasaka T, Costa M, Guagliumi G, Grube E, Ozaki Y, Pinto F, Serruys PW; Expert's OCT Review Document. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010 Feb;31(4):401-15. doi: 10.1093/eurheartj/ehp433. Epub 2009 Nov 4. Review.</citation>
    <PMID>19892716</PMID>
  </reference>
  <reference>
    <citation>Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003 Oct 7;108(14):1664-72. Review.</citation>
    <PMID>14530185</PMID>
  </reference>
  <reference>
    <citation>Zimarino M, Calafiore AM, De Caterina R. Complete myocardial revascularization: between myth and reality. Eur Heart J. 2005 Sep;26(18):1824-30. Epub 2005 Apr 11. Review.</citation>
    <PMID>15824076</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2011</study_first_submitted>
  <study_first_submitted_qc>April 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2011</study_first_posted>
  <last_update_submitted>June 4, 2015</last_update_submitted>
  <last_update_submitted_qc>June 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>G. d'Annunzio University</investigator_affiliation>
    <investigator_full_name>Raffaele De Caterina</investigator_full_name>
    <investigator_title>Director - Institute of Cardiology</investigator_title>
  </responsible_party>
  <keyword>NSTE-ACS</keyword>
  <keyword>PCI</keyword>
  <keyword>Thrombus Aspiration</keyword>
  <keyword>IVUS</keyword>
  <keyword>Periprocedural Myocardial Infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

